Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Ciscom Corp. Strengthens Its Board of Directors with Addition of Two Experienced Industry Leaders (click to learn more) Silver North Options GDR Silver Project, Silvertip-Midway District, Yukon (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MEDRELEAF CORP T.LEAF

Healthcare Drug Manufacturers - Specialty & Generic
"MedReleaf Corp is engaged in the production and sale of cannabis for medical purposes as regulated by the ACMPR, pursuant to its Licences and, in particular, its Markham Commercial Licence."


TSX:LEAF - Post by User

MEDRELEAF CORP > ACB $8.47*3.575 = $30.28 LEAF
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by jschrode42on May 28, 2018 8:57pm
118 Views
Post# 28091284

RE:RE:ACB $8.47*3.575 = $30.28 LEAF

RE:RE:ACB $8.47*3.575 = $30.28 LEAFDeal risk looks pretty low on this one. If you're going to get in anyway there's probably no advantage to waiting (in my opinion). 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities